This is to inform that the Board of Directors of the Company at its meeting held on Friday 24th October 2025 at 3.00 p.m. has considered and approved the following: 1.) Approved amendments ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Triochem Products' board, meeting on 24th October 2025, approved the sale of non-core immovable properties and plant & machinery located in Maharashtra. Total consideration is around Rs. 1,181 lakhs, paid in cash, based on fair market value from an independent valuer. Buyers are related parties: M/s. G Amphray Laboratories (a partnership firm where the company's directors and promoters are partners) purchasing assets worth Rs. 806 lakhs, and Director Mr. Rajesh Ranu Deora purchasing a residential flat in Lower Parel for Rs. 375 lakhs. The company clarified these are non-core, idle assets with no impact on operations, and proceeds will fund new business ventures. The deal requires shareholder approval via postal ballot (cut-off date 25th October 2025) and is expected to close by 31st January 2026.
This is an asset monetisation exercise, not a business divestiture — the company explicitly states no impact on operations and no change in shareholding pattern. Shareholders should watch for the postal ballot outcome and the final sale price, as this is a related-party transaction requiring their approval.